Xi Qin

9.8k total citations
20 papers, 286 citations indexed

About

Xi Qin is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Xi Qin has authored 20 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Xi Qin's work include RNA modifications and cancer (5 papers), Cancer-related gene regulation (5 papers) and Acute Myeloid Leukemia Research (2 papers). Xi Qin is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related gene regulation (5 papers) and Acute Myeloid Leukemia Research (2 papers). Xi Qin collaborates with scholars based in China, United States and Australia. Xi Qin's co-authors include Jing Lin, Qinong Ye, Long Cheng, Lihua Ding, Chunwei Yu, Jun Zhang, Yingying Wen, Hongshen Ma, Kerryn Matthews and Jenny Bazov and has published in prestigious journals such as Blood, Cancer Research and Scientific Reports.

In The Last Decade

Xi Qin

18 papers receiving 286 citations

Peers

Xi Qin

ONCOL

IMMUN

Delphi Van Haver Belgium

Jiamin Gao China

Sumana Mukherjee India

Tomas Koltai Italy

Pei‐Chen Hsu Taiwan

Emeline Cros‐Perrial France

Flaviana Cau Italy

Xiubing Zhang China

Elvin D. de Araujo Canada

Cristina Matteo Italy

Delphi Van Haver Belgium

Xi Qin

243 ×1.6

88 ×1.2

ONCOL

37 ×0.6

84 ×1.5

53 ×1.6

IMMUN

Citations per year, relative to Xi Qin Xi Qin (= 1×) peers Delphi Van Haver

Countries citing papers authored by Xi Qin

Since Specialization

Citations

This map shows the geographic impact of Xi Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Qin more than expected).

Fields of papers citing papers by Xi Qin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Qin. The network helps show where Xi Qin may publish in the future.

Co-authorship network of co-authors of Xi Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Qin. A scholar is included among the top collaborators of Xi Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Qin. Xi Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Hong, Y. Y. Ji, Shan Deng, et al.. (2025). SQYC formula improves the efficacy of PD-1 monoclonal antibodies in MSS colorectal cancer by regulating dendritic cell mitophagy via the PINK1-Parkin pathway. Phytomedicine. 138. 156388–156388. 2 indexed citations

Qin, Xi, Keren Zhou, Yang Lü, et al.. (2025). CRISPR screening reveals ZNF217 as a vulnerability in high-risk B-cell acute lymphoblastic leukemia. Theranostics. 15(8). 3234–3256.

Li, Xiaowen, Tong Wu, Weihong Chen, et al.. (2024). Andrographolide acts with dexamethasone to inhibit the growth of acute lymphoblastic leukemia CEM‑C1 cells via the regulation of the autophagy‑dependent PI3K/AKT/mTOR signaling pathway. Biomedical Reports. 20(3). 43–43. 2 indexed citations

Han, Li, Keith Leung, Zhicong Zhao, et al.. (2022). Abstract 3617: METTL16 drives leukemogenesis and maintains leukemia stem cell self-renewal via reprogramming BCAA metabolism. Cancer Research. 82(12_Supplement). 3617–3617. 2 indexed citations

Zhang, Mingfeng, Eun Ji Joo, Hisham Abdel‐Azim, et al.. (2021). Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia. Theranostics. 11(19). 9519–9537. 13 indexed citations

Qin, Xi, Rui Su, Lu Yang, et al.. (2019). Identification of ZNF217 As an Essential Oncogenic Gene in B-Cell Acute Lymphoblastic Leukemia By CRISPR/Cas9-Based Library Screening. Blood. 134(Supplement_1). 1465–1465. 1 indexed citations

Weng, Hengyou, Huilin Huang, Huizhe Wu, et al.. (2018). N6-Methyladenosine Modification Regulates Cell Metabolism in Acute Myeloid Leukemia. Blood. 132(Supplement 1). 880–880.

Qin, Xi, et al.. (2018). The change of synovial fluid proteome in rabbit surgery-induced model of knee osteoarthritis.. PubMed. 10(7). 2087–2101. 8 indexed citations

Wang, Yungui, Jennifer R. Skibbe, Chao Hu, et al.. (2017). ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia. Scientific Reports. 7(1). 1853–1853. 29 indexed citations

10.

Huang, Huilin, Hengyou Weng, Xi Qin, et al.. (2016). The N6-Adenine Methyltransferase METTL14 Plays an Oncogenic Role in Acute Myeloid Leukemia. Blood. 128(22). 1536–1536. 2 indexed citations

11.

Qin, Xi, Sunyoung Park, Simon P. Duffy, et al.. (2015). Size and deformability based separation of circulating tumor cells from castrate resistant prostate cancer patients using resettable cell traps. Lab on a Chip. 15(10). 2278–2286. 73 indexed citations

12.

Han, Feng, et al.. (2014). Association between the MDM2 T309G Polymorphism and Leukemia Risk: a Meta-analysis. Asian Pacific Journal of Cancer Prevention. 15(16). 6767–6772. 3 indexed citations

13.

Yu, Chunwei, Yingying Wen, Xi Qin, & Jun Zhang. (2014). A fluorescent ratiometric Cu²⁺ probe based on FRET by naphthalimide-appended rhodamine derivatives. Analytical Methods. 6(24). 9825–9830. 27 indexed citations

14.

Zhou, Zhichao, et al.. (2012). FHL1 and Smad4 synergistically inhibit vascular endothelial growth factor expression. Molecular Medicine Reports. 7(2). 649–653. 12 indexed citations

15.

Niu, Chang, Chaoyang Liang, Juntang Guo, et al.. (2011). Downregulation and growth inhibitory role of FHL1 in lung cancer. International Journal of Cancer. 130(11). 2549–2556. 65 indexed citations

16.

Wu, Qiang, Peng Zhou, Xi Qin, et al.. (2011). Cloning, expression, identification and bioinformatics analysis of Rv3265c gene from Mycobacterium tuberculosis in Escherichia coli. Asian Pacific Journal of Tropical Medicine. 4(4). 266–270. 11 indexed citations

17.

Qin, Xi, et al.. (2009). Correlations between hepatitis B virus genotypes and natural mutation of YMDD in Hainan. 15(7). 714–716. 1 indexed citations

18.

Xia, Qianfeng, et al.. (2009). Detection of PCR products using self-reporting duplex mutation primers. Journal of Clinical Pathology. 62(11). 1046–1048. 1 indexed citations

19.

Lin, Jing, Lihua Ding, Hao Zhang, et al.. (2009). Four and a half LIM domains 1 (FHL1) and receptor interacting protein of 140 kDa (RIP140) interact and cooperate in estrogen signaling. The International Journal of Biochemistry & Cell Biology. 41(7). 1613–1618. 29 indexed citations

20.

Xu, Xiaojie, Lihua Ding, Lingxue Wang, et al.. (2009). [Construction of human Egr-1 promoter and its response to ionizing radiation in tumor cells].. PubMed. 25(11). 973–5. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact